Allo-Transplant Tied to Better PFS in Advanced Cutaneous T-Cell Lymphomas
(MedPage Today) -- Allogeneic hematopoietic stem cell transplantation (HSCT) was associated with significant improvements in progression-free survival (PFS) in patients with advanced cutaneous T-cell lymphomas (CTCLs), according to the propensity...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news
More News: Cutaneous T cell lymphoma | Dermatology | Lymphoma | Skin | Stem Cell Therapy | Stem Cells | T-cell Lymphoma | Transplants